Evidence map›Paper›PMID 20878770›Full record

ArticleGlia2011

Interferon lambda inhibits herpes simplex virus type I infection of human astrocytes and neurons.

Jieliang Li, Shuxian Hu, Lin Zhou, Li Ye, Xu Wang, Jie Ho, Wenzhe Ho

Abstract read
In one paragraph

Article in Glia, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Jieliang LiDepartment of Pathology and Laboratory Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Shuxian Hu
Lin Zhou
Li Ye
Xu Wang
Jie Ho
Wenzhe Ho
Temple University · USUniversity of Minnesota Medical Center · US

Funding

Drug Abuse, Sustance P and HIVR01DA012815 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI HO, WENZHE · 2000 to 2013
$4.5M
Opioids, HIV/HCV and Host Cell Innate ImmunityR01DA022177 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI HO, WENZHE · 2007 to 2017
$2.9M
Opioids, LPS and HIVR01DA027550 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI HO, WENZHE · 2010 to 2014
$1.4M
NIDA NIH HHS DA12815NIDA NIH HHS DA22177NIDA NIH HHS DA27550NIDA NIH HHS R01 DA012815NIDA NIH HHS R01 DA022177NIDA NIH HHS R01 DA027550
6 · The paper itself

Abstract

Herpes simplex virus Type I (HSV-1) is a neurotropic virus that is capable of infecting not only neurons, but also microglia and astrocytes and can establish latent infection in the central nervous system (CNS). We investigated whether IFN lambda (IFN-λ), a newly identified member of IFN family, has the ability to inhibit HSV-1 infection of primary human astrocytes and neurons. Both astrocytes and neurons were found to be highly susceptible to HSV-1 infection. However, upon IFN-λ treatment, HSV-1 replication in both astrocytes and neurons was significantly suppressed, which was evidenced by the reduced expression of HSV-1 DNA and proteins. This IFN-λ-mediated action on HSV-1 could be partially neutralized by antibody to IFN-λ receptor. Investigation of the mechanisms showed that IFN-λ treatment of astrocytes and neurons resulted in the upregulation of endogenous IFN-α/β and several IFN-stimulated genes (ISGs). To block IFN-α/β receptor by a specific antibody could compromise the IFN-λ actions on HSV-1 inhibition and ISG induction. In addition, IFN-λ treatment induced the expression of IFN regulatory factors (IRFs) in astrocytes and neurons. Furthermore, IFN-λ treatment of astrocytes and neurons resulted in the suppression of suppressor of cytokine signaling 1 (SOCS-1), a key negative regulator of IFN pathway. These data suggest that IFN-λ possesses the anti-HSV-1 function by promoting Type I IFN-mediated innate antiviral immune response in the CNS cells.

Indexed as

Analysis of VarianceAntiviral AgentsAstrocytesCells, CulturedFluorescent Antibody TechniqueHerpesvirus 1, HumanHumansInterferon LambdaInterferonsInterleukinsNeuronsReverse Transcriptase Polymerase Chain ReactionVirus ReplicationAntiviral AgentsInterferon Lambdainterferon-lambda, humanInterferonsInterleukins

Identifiers

PMID20878770
PMCPMC3082435
OpenAlexW1969404855

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.